Find your path to Matthew
454 people in our graph can introduce you to Matthew.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Gisella de la Rocha to introduce you to Matthew
You →Gisella · together at Moderna (2021–2023) →Matthew
Ask Jamie Chen to introduce you to Matthew
You →Jamie · 4 people · together at Moderna →Matthew
Ask Sam Okafor to introduce you to Matthew
You →Sam · 7 people · together at Medicxi →Matthew
Sign up to find every way you can get introduced to Matthew
- Your email: the people you already email who know Matthew
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Matthew
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Experience
- Alnylam PharmaceuticalsVP - Clinical Researchcurrent2025 — present
- Myosana Therapeutics, IncAdvisorcurrent2025 — present
- Myosana Therapeutics, IncBoard Member and Chief Medical Advisor2025
- Myosana Therapeutics, IncBoard Member2021 — 2025Greater London
- Myosana Therapeutics, IncChief Executive Officer2023 — 2025London and Seattle
- MedicxiVenture Partner2023 — 2025London, England, United Kingdom
- ModernaSenior Director - Rare Disease Clinical Development2019 — 2023London and Boston
- PfizerMedical Director - Rare Diseases2018 — 2019Tadworth, Surrey, United Kingdom
- PfizerHealth and Value Team Leader2017 — 2018Walton Oaks
- PfizerGlobal Innovative Pharma Medical Affairs Manager - Cardiovascular2015 — 2017Walton Oaks
- King's College LondonBritish Heart Foundation Clinical Research Training Fellow2013 — 2015St Thomas' Hospital
- Guy's and St Thomas' NHS Foundation TrustBiomedical Research Centre Clinical Research Fellow2012 — 2013St Thomas' Hospital, London
Skills & more
Clinical Research48Medical Education27Healthcare28Medical Research11Interventional Cardiology8Clinical Trials9Medicine11Cardiovascular Disease7Hospitals6Clinical Cardiology5Cardiovascular Physiology5Internal Medicine6
+9 more
EpidemiologyCardiologyPharmacologyMedical StatisticsHealthcare ManagementGeneral MedicalMedical AffairsClinical DevelopmentPharmaceutical IndustryFrom Matthew's professional profile.
Frequently asked questions
- Who is Matthew Lumley?
- Chief Medical Advisor at Myosana Therapeutics
- Where did Matthew Lumley go to school?
- Matthew Lumley studied at Imperial College London (Bachelor of Medicine, Bachelor of Surgery (MBBS)); King's College London (Doctor of Philosophy (PhD), Cardiovascular Physiology and Clinical Research); The Faculty of Pharmaceutical Medicine (Diploma in Pharmaceutical Medicine, Pharmaceutical Medicine).
Same school
Also attended Imperial College London899
Deji SasegbonVP, Platform & Portfolio Operations at EchoVC PartnersMadison LenormandInvestor at DaphniPauline BoucherInvestor at DaphniLoubaba El AyoubiInvestor at NorthzoneGiovanni MariggiInvestor at MedicxiFrancois PrinslooInvestor at Medicxi
+ 893 more
Also attended King's College London415
Harry StebbingsFounder & General Partner at 20VCDominic JacquessonInvestor at Index VenturesJohn HortonInvestor at DN CapitalBob ThomasPartner at OxxKatherine JonesHealthcare Investment Lead at Hummingbird VenturesÖzge Gizem YerlikayaGeneral Counsel at Idacapital
+ 409 more
Shared employers
Also worked at Alnylam Pharmaceuticals24
Bret L. BostwickMD, FAAP, FACMG, Venture Advisor at Breyer CapitalKevin StarrInvestor at Third Rock VenturesJason RhodesPartner at Atlas VentureJohn MaraganoreAdvisor at Oak HC/FTVincent MilesExecutive Director at AbingworthEric HuangPartner at Delos Capital
+ 18 more
Also worked at Myosana Therapeutics, Inc1
Also worked at Medicxi23
Francesco De RubertisInvestor at MedicxiGiovanni MariggiInvestor at MedicxiRichard LeeInvestor at MedicxiGiovanni PericoliniInvestor at MedicxiVictoria TaylorInvestor at MedicxiFrancois PrinslooInvestor at Medicxi
+ 17 more
Also worked at Moderna34
Dave JohnsonCo-founder & CEO of Dash BioNoubar AfeyanInvestor at Flagship PioneeringGisella de la RochaVice President of Legal at MPM BioImpactAxel BouchonVenture Partner at ARCH Venture PartnersJordan SilvaCampus Lead at The MBA FundStephen BerensonManaging Partner Emeritus at Flagship Pioneering
+ 28 more







































